Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated that it has completed patient enrollment for the Hexvix® Phase III bridging trial.
Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated that it has completed patient enrollment for the Hexvix® Phase III bridging trial.